IBS C News and Research

RSS

New technique efficiently separates circulating tumor cells in bloodstream

A new research, affiliated with UNIST has been highlighted on the front cover of the January 2017 issue of the prestigious journal Analytical Chemistry. The key finding of this study is the development of a new technique that seperates circulating tumor cells from whole blood at a liquid-liquid interface.

7 Feb 2017

IBS scientists develop Nano MRI Lamp for smarter diagnosis of diseases

A research team led by CHEON Jinwoo at the Center for Nanomedicine, within the Institute for Basic Science, developed the Nano MRI Lamp: A new technology platform that tunes the magnetic resonance imaging signals "ON" only in the presence of the targeted disease.

6 Feb 2017

Food: the good, the bad and the ugly

As a society, we may be more obsessed with food than we've ever been. The alarming levels of obesity along with the rise of clean eating and orthorexia are perhaps just some indicators of the food-obsessed world we live in.

2 Feb 2017

Diet and antibiotic use can change gut microbiota contributing to IBS symptoms

A recent review of research suggests that changes to the microorganisms (microbiota) in the gastrointestinal (GI) tract may be a cause of irritable bowel syndrome (IBS).

27 Jan 2017

Impact of IBS on patients

The report reveals a quite alarming situation about the economic impact of IBS on healthcare system, society and patients themselves. In particular, it disclosed that there are a lot of hidden costs related to the utilization of healthcare resources by means of patients, frequently not recognized as IBS...

16 Jan 2017

Women with IBS experience worse quality of life than men, new research shows

Double work and a high embarrassment factor can lead to the quality of life being affected more among women than men by irritable bowel syndrome (IBS), a very common gastrointestinal disease.

9 Jan 2017

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Ardelyx, Inc., a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases, today announced the initiation of a Phase 3 clinical trial and an onset-of-action clinical trial evaluating RDX7675 in patients with hyperkalemia, a potentially life-threatening condition common in patients with cardiorenal disease.

3 Jan 2017

Bedfont introduces GastroCH4ECK Gastrolyzer to help detect gastrointestinal disorders

Bedfont Scientific has specialised in the design and manufacture of exhaled breath and gas monitoring instruments since 1976.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific’s Gastrolyzer range helps dietitians detect and treat dietary problems

This year Dietitian Week takes place between 6-10 June, marking the 3rd annual awareness week for Dietitians.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific’s Gastrolyzer monitors can help detect IBS through simple breath test

April is IBS awareness month and for the IBS Network's 25th Anniversary show, they are highlighting IBS from the patient's perspective.

From Bedfont® Scientific Ltd 5 Dec 2016

New study shows link between defective sucrase-isomaltase gene variants and IBS

Irritable bowel syndrome (IBS) affects a large portion of the general population. New research coordinated by Karolinska Institutet now shows a link between defective sucrase-isomaltase gene variants and IBS.

21 Nov 2016

FDA approves new assay for diagnosis of IBD

Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the US Food and Drug Administration clearance of QUANTA Lite Calprotectin Extended Range, an assay which aids in the diagnosis of Inflammatory Bowel Disease (IBD), and can help differentiate IBD from Irritable Bowel Syndrome (IBS).

16 Nov 2016

Identifying foods that trigger IBS: an interview with Dr Bill Chey

IBS is a common medical condition which is diagnosed in the presence of characteristic gastrointestinal symptoms including recurring bouts of abdominal pain and diarrhea and/or constipation. IBS patients also commonly report bloating and abdominal distension or swelling.

15 Nov 2016

New report underscores personal and economic impact of IBS

A multi-disciplinary expert group calls for greater attention to be paid to Irritable Bowel Syndrome (IBS) to bring it out of the shadows. The IBS Global Impact Report is launched at United European Gastroenterology Week and examines published studies on the direct and indirect costs of IBS.

19 Oct 2016

Alternative therapies appear to be effective in ameliorating IBS symptoms

A new review looks at the evidence behind the effectiveness of complementary or alternative therapies-including probiotics, prebiotics, synbiotics, fiber, and herbal medicinal products-for the treatment of bowel disorders such as irritable bowel syndrome (IBS), functional constipation, and ulcerative colitis.

3 Oct 2016

New partnership between BetterYou and University of Sheffield paves way for vitamin D research

A new collaboration between health pioneers BetterYou and scientists from the University of Sheffield, is paving the way for a three-year clinical trial looking at the effect of vitamin D supplementation on the quality of life of people with Irritable Bowel Syndrome (IBS).

From BetterYou Ltd 21 Sep 2016

Food intolerance testing: an interview with Dr Gill Hart

Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances.

15 Sep 2016

MR Solutions steps up sales of cryogen free, pre-clinical range of scanners

MR Solutions continues to grow sales of its cryogen free, pre-clinical range of scanners including its PET-MR and high field MR systems.

8 Sep 2016

New research shows independent gut-to-brain and brain-to-gut pathways operate in IBS patients

New research indicates that in patients with irritable bowedistinct brain-to-gut pathway, where psychological symptoms begin first, and separately a distinctl syndrome (IBS) or indigestion, there is a gut-to-brain pathway, where gut symptoms start first.

22 Jul 2016

Low-FODMAP rye bread may reduce symptoms of IBS

Patients with irritable bowel syndrome (IBS) are often concerned that certain foods may trigger or worsen their symptoms, which can include abdominal pain, diarrhea, or constipation. In a new study, patients who ate rye bread that was low in so-called "FODMAPs" (fermentable oligo- di- and mono-saccharides and polyols) experienced milder IBS symptoms than patients who ate normal rye bread.

18 Jul 2016